About this Event
THE WALTER SCOTT LECTURE
organized by the Department of Biochemistry and Molecular Biology
PRESENTED JOINTLY WITH DEAN HENRI R. FORD’S DISTINGUISHED LECTURE SERIES AND
ROBERT S. LANGER, Sc.D.
Institute Professor, Massachusetts Institute of Technology
“Biomaterials and Biotechnology: From the Discovery of the First Angiogenesis Inhibitors to the Development of Controlled Drug Delivery Systems and the Foundation of Tissue Engineering“
About the Speaker:
Robert Langer, Sc.D., has authored more than 1,500 articles, which have been cited more than 361,000 times. His h-index of 298 is the highest of any engineer in history and the fourth-highest of any individual in any field. His patents have been licensed or sublicensed to more than 400 companies, he is a co-founder of several companies, including Moderna, and he has served as Chairman of the FDA’s Science Board. Dr. Langer is the recipient of more than 220 awards, including the United States National Medal of Science and the United States National Medal of Technology and Innovation, making him one of three living individuals to have received both honors. He holds 36 honorary doctorates and has been elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences, and the National Academy of Inventors.
Advanced drug delivery systems are having an enormous impact on human health. We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies. This early research then led to new drug delivery technologies including nanoparticles and nanotechnology that are now being studied for use in treating cancer, many other illnesses, and in vaccine delivery (including the Covid-19 vaccine). We will also discuss approaches using materials and cells to create new tissues and organs, and also organs on a chip.
0 people are interested in this event